Order ready-to-submit essays. No Plagiarism Guarantee!
Note: All our papers are written from scratch by human writers to ensure authenticity and originality.
BHS-470 Introduction to Trauma-Informed Care
Check your essay before you submit. See exactly what your professor sees.
See your AI and plagiarism results before your instructor does.Get the exact same report your professor uses. Trusted by 50,000+ students worldwide.
HSM 410 Week 7 Course Project 2 (Death with Dignity Legislation)
(Death with Dignity Legislation)
Details of the Project
OUTLINE TITLE
I) Introduction.
A. History on the Death with Dignity legislation and what it actually means.
1) Definition of terminal illness (Terminal Illness n.d.)
2) Statistics of usage (Death with Dignity 2015)
3) Measures to prevent patients abusing the law (Cobbs et al 2015).
4) Oregon was a pioneer in the fight for Death with Dignity since it accepted it into law on November 8, 1994 (Reuter 2015).
5) Other states that have followed suit since then are Washington, Montana, and Vermont (Reuter 2015).
a) To date there are currently eleven states that are considering the Death with Dignity legislation during the current session (Korchnak, n.d.).
B. Who was Brittany Maynard and what she did to start this much needed conversation (Egan et al 2014).
1) Ethics of allowing someone to choose the day they will die.
a) The reasons that some people may choose this method to end their life.
b) The reasons that so many people oppose this method of physician assisted suicide.
II) The reasons that every state should pass this legislation.
A. How the terminally ill patient would benefit from using this legislation.
1) Challenges of the acceptance of the Death with Dignity Act (Stutsman 2015).
a) Finding a Physician and a second opinion.
b) Pharmacies rights and pricing.
c) Being allowed to live and die with the personal choice that was made.
III. Conclusion;
HSM 410 Week 7 Course Project 1 (Congress and Issues Regarding Specialty Pharmaceuticals)
Congress and Issues Regarding Specialty Pharmaceuticals
Details of the Project
OUTLINE TITLE
I. Specialty Pharmaceuticals
II. Legislation/policy analysis
A. Specialty Tiers.
B. Cost Sharing Burden.
III. Problem/issue addressed
A. Biosimilar Medications.
B. Generic Medications.
IV. History of the legislation
A. Drug Importation Act of 1848
B. Biologics Control Act of 1902.
C. Pure Foods and Drug Act of 1906.
D. Harrison Narcotic Act of 1914.
E. Food, Drug, and Cosmetic Act of 1938.
F. Amendments; Sherley Amendment of 1912, and the Humphrey Amendment of 1952.
V. Effectiveness in addressing the problem or issue
C. Ensuring the right medications get to the right people.
D. Responsibility of manufacturers, government, insurers, and physicians.
VI. Group(s) of people affected
E. Individuals with serious or chronic medical conditions.
VII. Future of this legislation
F. Growth in need for specialty pharmaceuticals.
G. Over-regulation of specialty pharmaceuticals.
VIII. Conclusion
